Giriş: Kronik öksürük çocuklarda sık görülen bir yakınmadır. Postinfeksiyöz nedenler, Mycoplasma pneumoniae, Chlamydia pneumoniae ve Bordetella pertussis infeksiyonlarını takiben daha sık görülen bir yakın-madır. Bu çalışmada kronik öksürüklü çocuklar American College of Chest Physicians (ACCP) tarafından önerilen algoritmaya göre tanı ve tedavi edilerek, M. pneumoniae ve C. pneumoniae serolojisi değerlen-dirilmiştir.
INTRODUCTION
Chronic chough is a problem frequently encountered in children resulting in parental distress [1, 2] . Th e diagnosis becomes easier in the presence of specifi c clinical fi ndings. In childhood, postinfectious causes play a major role in chronic cough. Th e pathogenesis of the postinfectious cough is not completely understood. It is thought to be the result of infl ammation and the epithelial damage in the upper and lower airways, with or without transient airway hyperresponsiveness [3] .
In children, a specifi c infectious agent causing postinfectious cough remains unidentifi ed in most cases. Respiratory viruses, Mycoplasma pneumoniae, Chlamydia pneumoniae, Bordetella pertussis and Moraxella catarrhalis have all been implicated [4] [5] .
Th is study aims to evaluate the role of M. pneumoniae and C. pneumoniae seropositivity in children with chronic cough and to ascertain the clinical diagnosis and response to treatment according to American College of Chest Physicians (ACCP) 2006 guideline [6] .
MATERIALS and METHODS
Th is study was conducted in Pediatric Allergy Unit of Izmir Dr. Behcet Uz Children's Hospital. School age children between 6 to 14 years, inclusive, who had been coughing longer than 4 weeks and having unremarkable chest x-ray and pulmonary function test (PFTs) were recruited. A comprehensive clinical history, including the length of cough, its association with physical eff ort, presence of dry or productive cough, and family history of atopic disease was obtained. Pathological fi ndings were evaluated and clinical examination was performed. Patients with fi ndings indicating pulmonary or cardiac diseases, known immune defi ciency, neuromotor developmental defi cit, or a previous diagnosis and treatment of asthma were all excluded. Permission was taken from the parents and local ethic committee for the study.
Patients were evaluated on the basis of 2006 ACCP guideline. Pulmonary function test and chest x-ray were performed in all patients aft er the medical history and physical examination. Th ey were reevaluated in 2 to 4 weeks intervals until cough disappeared. At study entry, a serum sample was analyzed for M. pneumoniae and C. pneumoniae antibody status using the enzyme-linked immunosorbent assay (Euroimmun-Germany, ELISA kits). Only one sample per patient was analyzed. 
Statistical Analysis
Normality of distribution of variables were tested with Kolmogorov-Smirnoff test. Results were presented as mean ± standard deviation or percentages (%). We
Conclusion:
In school-age children with chronic chough, M. pneumoniae and C. pneumoniae seropositivity is in high rates. Th ese microorganisms may cause chronic infl ammation in airway and this condition clinically appear as protracted bronchitis, upper airway cough syndrome and asthma-like disease.
used Mann-Whitney U test to compare the diff erences between groups in count variables. Qualitative variables were assessed with chi-squared test. A p value < 0.05 (2-tailed) was accepted as signifi cant. Data were analysed using SPSS for Windows version 15.0.
RESULTS
Th e study included 41 children, 27 of whom were female (65.9%). Th e mean age was 8.00 ± 1.96 years. 68% of the patients had wet cough. Th e demographic characteristics of the patients are shown in Table 1 .
In all patients, PFTs and chest x-rays were found normal. Clarithromycin (15 mg/kg/day for 10 days) was given to patients who had productive cough or were diagnosed as sinusitis. Inhaled steroid (Budesonide 400 mcg/day) was given to patients with dry cough.
M. pneumoniae IgM and IgG serology was assessed in all patients. IgM and/or IgG positivity was found in 17 (41.46%) of them. Seven cases had IgM positivity, three cases had both IgM and IgG positivity and seven cases had IgG positivity.
Th e seven cases with M. pneumoniae IgM positivity were distributed according to the algorithm as follows: three UACS, two asthma-like, one prolonged bronchitis + asthma-like and one case of M. pneumoniae respiratory infection. Cases with UACS received antihistamines and nasal steroids. At follow-up, two weeks later, clarithromycin was added to the treatment because the patients complaints changed suggesting sinusitis with productive cough and purulent postnasal discharge. In the control visit, cough had improved. In two cases who were evaluated as asthma-like, inhaled steroids were initiated. One case with prolonged bronchitis did not respond to clarithromycin, and developed dry cough, so inhaled steroid was initiated and the symptoms resolved ( Figure 1 . Evaluation of diagnosis and treatment of patients with M. pneumoniae IgM and/or IgG positivity).
C. pneumoniae serology was assessed in 35 patients. Among those, one case (2.8%) had IgM and 8 cases Th e duration of cough and its characteristics and the presence of familial atopic disease didn't signifi cantly diff er between seropositive and seronegative patient groups (p> 0.05).
In fi ve of the 35 patients evaluated for both C. pneumoniae and M. pneumoniae, both serologies were positive. One had M. pneumoniae IgM positivity and C. pneumoniae IgG positivity, two had M. pneumoniae and C. pneumoniae IgG positivity, two had M. pneumoniae IgM and IgG and C. pneumoniae IgG positivity.
DISCUSSION
In this study, in children with chronic cough, IgM positivity for M. pneumoniae and C. pneumoniae were found, 17.07% and 2.8%, respectively. IgG positivity which may also show the presence of persistent infection was 24.39% for M. pneumoniae and 22.8% for C. pneumoniae. IgM and/or IgG positivity for any one of the agents was 51.21%. Th is suggests that in school children with chronic cough, atypical pathogens have a major role. When these patients are evaluated according to the 2006 ACCP guideline, these patients can be classifi ed as having asthma-like disease, UACS or protracted bronchitis.
C. pneumoniae and M. pneumoniae are common causes of acute lower and upper respiratory infection in children. However, the patients may also remain totally asymptomatic. In some cases of persistent cough lasting more than two weeks, unresponsive to conventional treatment, the clinicians consider these two microorganisms in their diagnosis. M. pneumoniae infections are reported to account for 70% of all cases aged 9-15 years. Th e 20 % of children infected with C. pneumoniae are also found co-infected with M. pneumoniae [7, 8] .
Although many methods (e.g ELISA, MIF, PCR) are used for diagnosis, the most reliable diagnostic test is the enzyme immunoassay [9, 10, 11] . Th e diagnosis of these organisms is clinically based on serologic response because culturing of these agents is diff ucult and timeconsuming. Th ere is no universal agreement upon gold standart serological assay for detection of antibody. Th e sensitivity of the serological response to M. pneumoniae infection depends on whether the sera are collected early or late aft er the onset of disease. Usually, a second serum sample is needed to demostrate seroconversion in 2-4 weeks interval [11] . In our study, only one serum sample was analyzed because the patients' complaints were chronic.
While the pathogenesis of the postinfectious cough is not known, it is thought to be the result of extensive disruption of epithelial integrity and widespread airway infl ammation of the upper and /or lower airways with or without transient airway hyperresponsiveness [12] . Th erefore, it is likely that transient infl ammation of the lower airways is important for the pathogenesis in some patients with postinfectious cough. Th is speculation is based on the fact that cough may be induced by the heightened responsiveness of the cough receptors, by bronchial hyperresponsiveness as seen in cough-variant asthma, or by impaired mucociliary clearance from the disruption of the epithelial lining of the airways. Since airway infl ammation causes mucus hypersecretion, retained secretions resulting from excessive mucus production and decreased clearance may be another important mechanism of cough. In addition, persistent infl ammation of the upper airway, particularly the nose and paranasal sinuses, can contribute to postinfectious cough [13] .
Another mechanism to consider in postinfectious cough is gastroesophageal refl ux. Th e vigorous coughing that follows may induce or aggravate preexisting refl ux disease because of the high abdominal pressures that are generated [14, 15] . In our study, the C. pneumoniae IgM positivite patient who was diagnosed with UACS also had symptoms suggesting GERD. Th is patient's complaint was resolved with antirefl ux treatment. C. pneumoniae is an obligate intracellular organism, whereas, M. pneumoniae is an extracellular pathogen. Both may cause prolonged symptoms. Chronic infections related to C. pneumoniae were shown to cause ciliary dysfunction of bronchial cells and epithelial damage [16, 17] .
On the other hand, M. pneumoniae was suggested to cause disruption in ciliated epithelial cells by adhering airway mucosa. Both pathogens may cause pneumonia, interstitial pneumonia, bronchitis, bronchiolitis and pharyngitis in children as well as adults [18] [19] [20] .
In a study evaluating M. pneumoniae and C. pneumoniae seroprevalence in stable asthma and chronic obstructive pulmonary disease, M. pneumoniae was seropositive in 11.1% and C. pneumoniae in 8.3% of cases in the asthma group [21] . In children with chronic persistent asthma, C. pneumonia IgG was detected in 40.62% [22] . In another study examining C. pneumoniae infection in adults with persistent cough, serological fi ndings for acute Chlamydial infections were reported in 6.5% of cases, while M. pneumoniae was positive in 18.5% of cases [4] . In a study evaluating M. pneumoniae and C. pneumoniae serologies and treatment in children with chronic and recurrent cough, 67 patients aged between 2,5 and 16 years old, M. pneumoniae was positive in 29%, C. pneumoniae in 6%, and M. pneumoniae IgG in 47.8% of cases. In the same trial, more than one cause was also determined. While some of the cases improved without clarithromycine, others improved with only anti-asthmatics and nasal steroids [18] . In our study, IgM positivity for M. pneumoniae and C. pneumoniae were found to be 17.07% and 2.8%, respectively. IgG positivity which may also show the presence of persistent infection was 24.39% for M. pneumoniae and 22.8% for C. pneumoniae. IgM and/or IgG positivity for any one of the agents was 51.21%. In a study from Turkey that investigated serologic markers of C. pneumoniae in healthy children, IgM and IgG seropositivity in C. pneumoniae was 1.2% and 18.7% respectivitly [24] . In another study that investigated the role of M. pneumoniae and C. pneumoniae in children with community-acquired pneumonia in İstanbul, M. pneumoniae infection was diagnosed in 27%, C. pneumonia infection in 2% [25] . Th e results of our study revealed similar seropositivity in children with chronic cough.
Th is study evaluates the serology of M. pneumoniae and C. pneumoniae in children with chronic cough. Usually, in diagnosis of an acute infection, it is recommended that two serum samples should be obtained in 2-4 weeks interval. However, we analyzed one serum sample, because these patients' complaints were chronic. High seropositivity was found for these agents that could be considered to match with the results in community acquired pneumonia. Actually, the serological results should be compared with those in healthy school children. Th is study did not include a control group. When the children's respiratory complaints are chronic, they should be evaluated in a diagnostic algorithm to start antibiotics eff ective against atypical agents, if necessary.
